<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:44:20Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3354769" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3354769</identifier><datestamp>2012-11-01</datestamp><setSpec>nihpa</setSpec><setSpec>pmc-open</setSpec><setSpec>manuscript</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">100890575</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">21417</journal-id>
      <journal-id journal-id-type="nlm-ta">Nat Cell Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat. Cell Biol.</journal-id>
      <journal-title-group>
        <journal-title>Nature cell biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1465-7392</issn>
      <issn pub-type="epub">1476-4679</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3354769</article-id>
      <article-id pub-id-type="pmcid">PMC3354769</article-id>
      <article-id pub-id-type="pmc-uid">3354769</article-id>
      <article-id pub-id-type="pmid">22484487</article-id>
      <article-id pub-id-type="pmid">22484487</article-id>
      <article-id pub-id-type="doi">10.1038/ncb2473</article-id>
      <article-id pub-id-type="manuscript">nihpa360591</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Distinct and separable activities of the endocytic clathrin coat components Fcho1/2 and AP-2 in developmental patterning</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Umasankar</surname>
            <given-names>P. K.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanker</surname>
            <given-names>Subramaniam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thieman</surname>
            <given-names>James R.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chakraborty</surname>
            <given-names>Souvik</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wendland</surname>
            <given-names>Beverly</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsang</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Traub</surname>
            <given-names>Linton M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="CR1">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 USA
</aff>
      <aff id="A2"><label>2</label>Department of Biology, The Johns Hopkins University, Baltimore, MD 21218 USA
</aff>
      <aff id="A3"><label>3</label>Department of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213 USA
</aff>
      <author-notes>
        <corresp id="CR1"><label>4</label>To whom correspondence should be addressed at: Department of Cell Biology University of Pittsburgh School of Medicine 3500 Terrace Street, S311 BST Pittsburgh, PA 15261 Tel: (412) 648-9711 Fax: (412) 648-9095 <email>traub@pitt.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>9</day>
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>14</volume>
      <issue>5</issue>
      <fpage>488</fpage>
      <lpage>501</lpage>
      <!--elocation-id from pubmed: 10.1038/ncb2473-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P1">Clathrin-mediated endocytosis occurs at multiple independent import sites on the plasma membrane, but how these positions are selected and how different cargo is simultaneously recognized is obscure. FCHO1 and FCHO2 are early-arriving proteins at surface clathrin assemblies and are speculated to act as compulsory coat nucleators, preceding the core clathrin adaptor AP-2. Here, we show the Î¼-homology domain (Î¼HD) of FCHO1/2 represents a novel endocytic interaction hub. Translational silencing of <italic>fcho1</italic> in zebrafish embryos causes strong dorsoventral patterning defects analogous to Bmp signal failure. The Fcho1 Î¼HD interacts with the Bmp receptor Alk8, uncovering a new endocytic component that positively modulates Bmp signal transmission. Still, the <italic>fcho1</italic> morphant phenotype is distinct from severe embryonic defects apparent when AP-2 is depleted. Our data thus contradict the primacy of FCHO1/2 in coat initiation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S1">
      <title>INTRODUCTION</title>
      <p id="P2">Clathrin-mediated endocytosis is a major mechanism for the selective internalization of cell surface components and extracellular macromolecules<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup>. The import sites contain clathrin triskelia assembled into a polygonal lattice<sup><xref rid="R3" ref-type="bibr">3</xref></sup>. As the lattice curves by incorporating pentagonal facets and projects into the cell interior, select cargo is packaged into the clathrin-coated invagination. Preferential retention of cargo within the bud depends on cytosol-oriented sorting signals<sup><xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref></sup>. A heterotetrameric AP-2 adaptor complex and numerous clathrin-associated sorting proteins (CLASPs) identify structurally disparate sorting signals<sup><xref rid="R6" ref-type="bibr">6</xref></sup>; this recognition allows non-competitive grouping of dissimilar cargo into single clathrin-coated buds. The processes of coat assembly, cargo capture and budding takes less than a minute, and eukaryotic cells have hundreds of spatially-discrete clathrin-coated structures forming on the surface<sup><xref rid="R3" ref-type="bibr">3</xref></sup>. Precisely how buds initiate at defined locations is unclear<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>. Certainly, phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P<sub>2</sub>) is pivotal since depleting this lipid triggers swift dissolution of surface coats<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>. Because AP-2 and numerous CLASPs and clathrin accessory proteins bind physically to PtdIns(4,5)P<sub>2</sub>, current models invoke stochastic but simultaneous encounters of these molecules with PtdIns(4,5)P<sub>2</sub>, themselves, cargo and clathrin to begin coat polymerization on a patch of membrane<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Recently, however, on the basis of two PtdIns(4,5)P<sub>2</sub>-binding proteins invariantly preceding the arrival of AP-2 and clathrin at nascent bud sites, FCH domain only 1 (FCHO1) and FCHO2 were proposed to be functionally redundant pioneer proteins demarcating sites of future clathrin assembly<sup><xref rid="R12" ref-type="bibr">12</xref></sup>.</p>
      <p id="P3">Here, we examine the endocytic activity of the modular FCHO1 and FCHO2 proteins to address the following questions: What molecular interactions distinguish the various protein domains? What role do Fcho1 and Fcho2 play in zebrafish embryonic development? Are Fcho1 and Fcho2 functionally interchangeable? And, if FCHO1/2 is obligatory for clathrin-coat nucleation, does the phenotype of Fcho1+2-compromised embryos parallel that of AP-2 morphants? We find Fcho1 operates during dorsoventral (DV) patterning of the embryo and associates with activin receptor-like kinase 8 (Alk8/<italic>lost-a-fin</italic>), a type I BMP receptor involved in signaling ventral cell fates<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>. Yet AP-2 depletion causes a much more penetrant, broadly severe and earlier developmental phenotype, indicating AP-2 function is not dependent on Fcho1/2.</p>
    </sec>
    <sec sec-type="results" id="S2">
      <title>RESULTS</title>
      <p id="P4">FCHO1 and FCHO2 are members of the muniscin subfamily of EFC domain proteins evolutionarily conserved from unicellular eukaryotes to mammals<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>. These paralogues play a functionally redundant role beginning at the earliest assembly stages of clathrin-mediated endocytosis<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup>. HeLa cells express transcripts for both FCHO1 and FCHO2 but endogenous FCHO1 protein is undetectable with antibodies<sup><xref rid="R19" ref-type="bibr">19</xref></sup>. Transient expression of GFP-tagged FCHO1 reveals scattered bright puncta on the ventral surface, but a diffuse membrane-tethered population becomes evident with higher over-expression (<xref ref-type="supplementary-material" rid="SD8">Fig. S1a</xref>). The heterogeneously sized fluorescent structures in cells expressing low-level GFP-FCHO1 colocalize with AP-2 but are spatially distinct from peripheral APPL1-positive endosomes or more centrally positioned EEA1-positive endosomes (<xref ref-type="supplementary-material" rid="SD8">Fig. S1b-e</xref>)<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. More abundant endogenous FCHO2 populates similar punctate structures to GFP-FCHO1 at steady state with considerable (~75%) overlap, although not perfect coincidence, with AP-2 (<xref ref-type="supplementary-material" rid="SD8">Fig. S1f-i</xref>). These findings confirm FCHO1/2 operate at clathrin-coated structures at the cell surface.</p>
      <sec id="S3">
        <title>The FCHO endocytic hub</title>
        <p id="P5">FCHO1 and FCHO2 are modular proteins (<xref ref-type="supplementary-material" rid="SD8">Fig. S1j</xref>). The N-terminal EFC domain is connected to a ~280 residue C-terminal Î¼HD by a linker of differing length in the paralogues. The first 270 residues of human FCHO1 and FCHO2, encoding a helical EFC domain monomer<sup><xref rid="R21" ref-type="bibr">21</xref></sup>, are 58% identical. Accordingly, dose-dependent association of purified FCHO1 EFC domain with PtdIns(4,5)P<sub>2</sub>-containing liposomes parallels that of the FCHO2 (<xref ref-type="supplementary-material" rid="SD8">Fig. S1k</xref>)<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup>. Binding to liposomes lacking PtdIns(4,5)P<sub>2</sub> is ~10-fold less efficient. The membrane binding and curvature sensing/inducing properties<sup><xref rid="R21" ref-type="bibr">21</xref></sup> of the antiparallel EFC domain dimer in FCHO1 and FCHO2 are thus similar.</p>
        <sec id="S4">
          <title>The linker region</title>
          <p id="P6">Protein disorder predictions indicate the EFC- and Î¼HD-separating residues (300-600) of FCHO1 comprise a low-complexity, largely unstructured segment. Intrinsic disorder is a hallmark of numerous endocytic factors that bind AP-2 utilizing short, tandemly-arrayed peptide motifs in the flexible region<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup>. GST-fusion proteins encompassing the central portion of FCHO1 engage AP-2 in pull-down assays (<xref ref-type="fig" rid="F1">Fig. 1a, b</xref>). The apparent affinity of this association with AP-2 is weaker than the C-terminal segment of ARH, which engages AP-2 with a <italic>K</italic><sub>D</sub> of ~1 Î¼M<sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref></sup>. The major AP-2 interaction determinant(s) in FCHO1 is between residues 267-442 (<xref ref-type="fig" rid="F1">Fig. 1a, b</xref>). Unlike ARH, the central segment of FCHO1 does not bind clathrin directly (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). FCHO2 does not associate with AP-2 (<xref ref-type="supplementary-material" rid="SD9">Fig. S2a</xref>); the shorter central linker in FCHO2 displays &lt;30% identity with FCHO1, probably explaining the absence of an AP-2 interaction motif(s).</p>
          <p id="P7">FCHO1 binds AP-2 through the globular appendage domain of the large Î± subunit, but some association with the Î²2-subunit appendage is also evident (<xref ref-type="fig" rid="F1">Fig. 1c</xref>). The contact site upon the Î± appendage is the platform subdomain since a W840A substitution abolishes binding (<xref ref-type="fig" rid="F1">Fig. 1d</xref>); a sandwich subdomain disruption (Q782A)<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> has no effect on binding. Yet RNAi suppression of AP-2, causing pronounced accumulation of dispersed transferrin receptors at the cell surface<sup><xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>, is still compatible with surface-clustered FCHO1 or -2 puncta (<xref ref-type="fig" rid="F1">Fig. 1e-l</xref>) also containing clathrin (<xref ref-type="fig" rid="F1">Fig. 1m</xref>) and eps15 (<xref ref-type="supplementary-material" rid="SD9">Fig. S2b</xref>), in line with these proteins being constituents of a pioneer unit<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R17" ref-type="bibr">17</xref></sup>. AP-2 depletion is seen on immunoblots (<xref ref-type="fig" rid="F1">Fig. 1n</xref>). Thus, despite binding AP-2, the heterotetramer is not necessary for FCHO1 (or FCHO2) surface puncta. This is consistent with FCHO2 not contacting AP-2 directly and also supported by truncation analysis; while full-length GFP-FCHO1 (1-889) masses at AP-2 patches, GFP-FCHO1 (1-275) and (1-609) are diffusely plasma membrane associated (<xref ref-type="fig" rid="F1">Fig. 1o-q</xref>) while GFP-FCHO1 (265-467) and (265-609) are cytosolic (<xref ref-type="supplementary-material" rid="SD9">Fig. S2</xref>). By contrast, GFP-Î¼HD (609-889) populates clathrin spots, albeit not as efficiently as the full-length protein (<xref ref-type="fig" rid="F1">Fig. 1r</xref>). Precise deposition of FCHO1 at clathrin foci therefore depends, in part, on the C-terminal Î¼HD.</p>
        </sec>
        <sec id="S5">
          <title>The Î¼HD</title>
          <p id="P8">Muniscins associate with eps15<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>. Reciprocal pull-down assays using a GST fusion with the C-terminus of eps15 (595-896) confirm binding requires the Î¼HD (<xref ref-type="fig" rid="F2">Fig. 2a</xref>). Î¼HDs also associate with intersectin 1 (<xref ref-type="fig" rid="F2">Fig. 2b</xref>), another EH (and SH3) domain scaffold protein involved in clathrin-mediated endocytosis<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup> that heterooligomerizes with eps15<sup><xref rid="R32" ref-type="bibr">32</xref></sup>. Yet, unlike the AP-2 Î±-subunit appendage, which also binds eps15 and intersectin to a similar extent, the Î¼HDs do not interact with endocytic factors like AP180, amphiphysin or epsin 1. The capacity of FCHO1/2 to associate with membranes in a PtdIns(4,5)P<sub>2</sub>-dependent manner and engage AP-2 and other core endocytic components (eps15, intersectin) distinguishes these proteins as dedicated endocytic factors. This is consistent with positioning of FCHO1/2 at clathrin structures on the plasma membrane (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
          <p id="P9">The FCHO1/2 Î¼HDs also associate with eps15, eps15R, and intersectin in HeLa lysates. In addition, Dab2, Hrb and CALM, three tandem Asn-Pro-Phe-containing CLASPs bind the Î¼HDs in a concentration-dependent manner (<xref ref-type="fig" rid="F2">Fig. 2c</xref>). Three observations rule out that these associations are indirect and mediated by Asn-Pro-Phe sequences binding to the EH domain scaffolds (eps15/R and intersectin). First, Dab2, Hrb and CALM binding does not parallel binding of the EH domain proteins to GST-Î¼HDs. Second, Hrb and CALM bind efficiently to only the FCHO1 Î¼HD and neither FCHO2 nor SGIP1, despite all exhibiting robust eps15 and intersectin interactions. Third, preincubating HeLa lysates with GST-FCHO2 Î¼HD removes the majority of eps15 and intersectin, but remaining Hrb and CALM engage GST-FCHO1 Î¼HD in second-stage incubations indistinguishably from GST-preincubated lysate (<xref ref-type="fig" rid="F2">Fig. 2d</xref>). This reveals that association of Dab2, Hrb and CALM with the FCHO1 Î¼HD is independent of EH domain proteins and highlights a functional difference between FCHO1 and FCHO2/SGIP1 Î¼HDs.</p>
          <p id="P10">The Asp-Pro-Phe tripeptide-rich C terminus of eps15 was used to delineate the FCHO1 Î¼HD-binding region (<xref ref-type="fig" rid="F2">Fig. 2e, f</xref>). A limited tract positioned between eps15 residues ~600 and 660 is recognized by the Î¼HD. Since this short eps15 (595-660) peptide efficiently competes with cytosolic Hrb, CALM and Dab2 in assays at lower concentrations than required to displace eps15R, intersectin or eps15 (<xref ref-type="fig" rid="F2">Fig. 2g</xref>), all likely engage the FCHO1 Î¼HD through a common or partly overlapping interaction surface, but with the scaffolds binding with higher apparent affinity. Numerous important accessory proteins and CLASPs thus converge on the FCHO1 Î¼HD (<xref ref-type="fig" rid="F2">Fig. 2h</xref>) and, therefore, like the AP-2 appendage domains<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>, this domain represents a novel endocytic hub.</p>
        </sec>
      </sec>
      <sec id="S6">
        <title>FCHO1 affects embryogenesis</title>
        <p id="P11">Misexpression of mammalian FCHO1 in zebrafish confirms the Î¼HD importance. On microinjecting synthetic GFP-FCHO1 (1-889) mRNA into 1-cell stage embryos, fluorescence is visible during the early gastrula period, ~5 hours post fertilization (hpf) (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). Coinjection of a membrane-tethered RFP marker shows GFP-FCHO1 concentrates at the blastomere plasma membrane, but in discontinuous puncta as opposed to the uninterrupted RFP. The punctate GFP-FCHO1 pattern overlaps with endogenous AP-2 (<xref ref-type="fig" rid="F3">Fig. 3b, c</xref>). By 24 hpf, microinjected ectopic mammalian FCHO1 produces a gain-of-function phenotype. Unlike controls, the FCHO1-expressing embryos are cyclopic and mildly ventralized, with small head regions, misshapen trunk somites, and loss of notochord tissue in severely affected embryos (<xref ref-type="fig" rid="F3">Fig. 3d-j</xref>). Comparative <italic>in situ</italic> localization of transcripts for dorsally specified axial mesoderm, <italic>no-tail</italic> and <italic>sonic hedgehog,</italic> confirms disruption of dorsal patterning. Strikingly, misexpression of similar amounts of a Î¼HD-truncated FCHO1 (1-609; ÎÎ¼HD) mRNA leads to strong dorsalization (<xref ref-type="fig" rid="F3">Fig. 3k</xref>). Embryos now show posteriorly shortened and twisted body axes, loss of the yolk extension and tail. The most severe resemble C4/C5 category <italic>snailhouse</italic> (<italic>bmp7</italic>) and <italic>swirl</italic> (<italic>bmp2b</italic>) mutant embryos<sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup>. Injection of FCHO1 Î¼HD (609-889) mRNA alone phenocopies FCHO1 (1-609) overexpression (<xref ref-type="fig" rid="F3">Fig. 3j, l</xref>) indicating that the dominant-negative effect derives from uncoupling the linked domains and that the normal operation of FCHO1 requires physical connection of the EFC and Î¼HD regions. These reciprocal dysmorphic effects suggest muniscins participate in early embryogenesis. In fact, because DV patterning is governed in part by Bmp signaling<sup><xref rid="R35" ref-type="bibr">35</xref></sup>, Fcho1 may assist operation of Bmp receptors during gastrulation. The Smad1/5/8 transcription factors are direct phosphotargets of the type I Bmp receptor Alk8<sup><xref rid="R36" ref-type="bibr">36</xref></sup>, and phosphoSmad (pSmad1/5/8) localization is grossly misplaced dorsally in constitutively-active (CA*) <italic>alk8</italic> mRNA-injected embryos (<xref ref-type="fig" rid="F3">Fig. 3m, n</xref>). Likewise, ectopic FCHO1 expression drives notable, but weaker, dorsal expansion of nuclear pSmad1/5/8 localization in gastrulas (<xref ref-type="fig" rid="F3">Fig. 3o-s</xref>), indicating hyperactive Bmp signaling.</p>
      </sec>
      <sec id="S7">
        <title><italic>D. rerio</italic> Fcho1 and Fcho2 in DV patterning</title>
        <p id="P12">A single gene encodes Fcho1 (LOC565812) and Fcho2 (ZDB-GENE-050522-228) in zebrafish. The structural and topological features are conserved in the teleost proteins (<xref ref-type="supplementary-material" rid="SD10">Fig. S3</xref>) and maternally deposited transcripts for both Fcho1 and Fcho2 are present; RT-PCR confirms the presence of the appropriate gene-specific amplicons while <italic>in situ</italic> hybridization shows localization in four-cell embryos through shield stage (when gastrulation begins) at ~6 hpf (<xref ref-type="supplementary-material" rid="SD10">Fig. S3</xref>). After the onset of general zygotic transcription (~3 hpf), both <italic>fcho1</italic> and <italic>fcho2</italic> transcripts are still detectable and increase gradually through the segmentation period to 24 hpf. Both <italic>fcho1</italic> and <italic>fcho2</italic> messages are broadly distributed but, by 24 hpf, regional differences are apparent; expression patterns are therefore overlapping but not identical.</p>
        <p id="P13">Injecting an initiation codon-targeting <italic>fcho1</italic> antisense morpholino oligonucleotide (MO) (<xref ref-type="supplementary-material" rid="SD11">Fig. S4</xref>) at the 1-cell stage causes a strong dorsalized phenotype at 24 hpf, where structures originating from the dorsal side predominate with accompanying loss of ventral tissues (<xref ref-type="fig" rid="F4">Fig. 4a-g</xref>). Again, severely affected embryos mirror <italic>snailhouse</italic> and <italic>swirl</italic> mutants. The phenotype is dose dependent with increased lethality at higher MO concentrations. MO efficacy is verified by silencing of an appropriate <italic>fcho1</italic>-GFP reporter (<xref ref-type="supplementary-material" rid="SD11">Fig. S4</xref>) and the phenotype is not markedly different in <italic>p53</italic> MO-coinjected embryos<sup><xref rid="R37" ref-type="bibr">37</xref></sup>. Earlier in development, at the end of gastrulation (~10 hpf), the <italic>fcho1</italic> morphants are oblong (<xref ref-type="fig" rid="F4">Fig, 4h, i</xref>), typical of dorsalization<sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup>. These morphological abnormalities accompany gene expression pattern changes diagnostic for dorsalization: the positioning of the hindbrain marker <italic>krox20</italic> reveals laterally-expanded stripes compared with controls, while, in the same embryos, expression of <italic>gata1</italic>, a marker of the ventrally-specified erythroid lineage, is diminished (<xref ref-type="fig" rid="F4">Fig. 4j-m</xref>). Also in line with expansion of dorsal cell fates, regional mRNA expression of the dorsally positioned Bmp antagonist Chordin (<xref ref-type="fig" rid="F4">Fig. 4n</xref>) is widened ventrally in shield stage <italic>fcho1</italic> morphants (<xref ref-type="fig" rid="F4">Fig. 4o, p</xref>). Reciprocally, the lateral <italic>bmp4</italic> expression field is variably reduced ventrally, consistent with suppression of positive feedback of <italic>bmp</italic> expression by Bmp signaling in the ventral region (<xref ref-type="fig" rid="F4">Fig. 4q, r</xref>)<sup><xref rid="R38" ref-type="bibr">38</xref></sup>. During segmentation, the <italic>fcho1</italic> morphants have laterally broadened somitic mesoderm (<xref ref-type="fig" rid="F4">Fig. 4s, t</xref>) that could reflect delayed/abnormal convergenceâextension movements. Defective convergence likely reflects a second function of the Bmp gradient in the gastrula: proper locomotion of cells to the midline by modulating cell adhesion<sup><xref rid="R39" ref-type="bibr">39</xref></sup>.</p>
        <p id="P14">Administering full-length FCHO1 mRNA together with the <italic>fcho1</italic> MO increases morphologically normal 24 hpf embryos to 67% from 12% with the MO alone (<xref ref-type="fig" rid="F4">Fig. 4u-y</xref>). There is &gt;5 bp mismatch with the FCHO1 RNA (<xref ref-type="supplementary-material" rid="SD11">Fig. S4</xref>) excluding the coinjected transcript titrates out the <italic>fcho1</italic> MO. Injection of the ÎÎ¼HD-encoding (1-610) transcript does not similarly correct development in <italic>fcho1</italic> morphants arguing that the basis for the DV patterning defect is Fcho1 insufficiency and that the intact protein is necessary for proper function.</p>
        <p id="P15">Because FCHO1 and FCHO2 are functionally redundant<sup><xref rid="R12" ref-type="bibr">12</xref></sup> a translation-blocking <italic>fcho2</italic> MO was also analyzed. The <italic>fcho2</italic> morphants differ strikingly from <italic>fcho1</italic> despite globally similar expression profiles during early embryogenesis (<xref ref-type="supplementary-material" rid="SD12">Fig. S5</xref>). The largely distinct developmental defects of the morphants indicate that Fcho1 and Fcho2 regulate separate events during zebrafish gastrulation and segmentation, but may also reflect temporal and regional differences in the expression of the two paralogues. There is evidence of weak overlapping function during embryogenesis: although <italic>fcho1+2</italic> MOs combined do not provoke a gross phenotype distinct from <italic>fcho1</italic> MO alone, the <italic>krox20</italic> lateral expansion, elliptical morphology, and spectrum of dorsalized embryos is slightly more severe in <italic>fcho1+2+p53</italic>-injected embryos than in <italic>fcho1+p53</italic>- treated ones (<xref ref-type="supplementary-material" rid="SD12">Fig. S5l-r</xref>).</p>
      </sec>
      <sec id="S8">
        <title>Fcho1 binds to Alk8</title>
        <p id="P16">As the general <italic>fcho1</italic> MO phenotype mirrors Bmp antagonism, we investigated interaction between Fcho1 and Alk8, an early DV patterning type I receptor for Bmp2bâBmp7<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup>. A genetic link between <italic>fcho1</italic> and <italic>alk8</italic> is revealed by co-injection of MOs targeting the two transcripts at levels (0.5 ng) that, alone, do not produce many dorsalized embryos (<xref ref-type="fig" rid="F5">Fig. 5a-e</xref>). When combined, mildly dorsalized (C2) embryos result with defective ventral tail fin development that resembles 5 ng <italic>alk8</italic> morphants, suggesting that Alk8 and Fcho1 operate along the same pathway. This conclusion is directly substantiated biochemically. C-terminally myc-tagged Alk8 in detergent lysates from transfected HeLa cells is bound by GST-FCHO1 Î¼HD dose-dependently, along with the other binding partners (<xref ref-type="fig" rid="F5">Fig. 5f-h</xref>). Also, Alk8-myc interacts with the immobilized cognate GST-Fcho1 Î¼HDs (~55% identical) while neither the Fcho2 (<xref ref-type="fig" rid="F5">Fig. 5f</xref>), FCHO2 nor SGIP1 Î¼HD (<xref ref-type="supplementary-material" rid="SD13">Fig. S6</xref>) bind similarly, despite equivalent eps15 interactions. The strong, differential interaction of the Fcho1/FCHO1 Î¼HD with Alk8 is clearly consistent with the differing phenotypes in <italic>fcho1</italic> or <italic>fcho2</italic> MO embryos. There is no obvious preference of the Fcho1 Î¼HD for binding to CA*Alk8 Q204D mutant<sup><xref rid="R41" ref-type="bibr">41</xref></sup> over the wild-type receptor (<xref ref-type="fig" rid="F5">Fig. 5g</xref>), whereas the related Alk1 interacts with the Î¼HD comparatively weakly (<xref ref-type="supplementary-material" rid="SD13">Fig. S6</xref>). The Î¼HD interaction with Alk8 is similar to Hrb binding and both are displaced by the eps15 (595-660) peptide at low concentrations (<xref ref-type="fig" rid="F5">Fig. 5h</xref>); so Alk8 does not appear to use a tyrosine-based sorting signal to engage the Fcho1 Î¼HD.</p>
        <p id="P17">Injecting <italic>bmp2b</italic>+<italic>bmp7</italic> mRNA elicits strong ventralization although coinjection with <italic>fcho1+2</italic> MOs results in genetic suppression, with primarily dorsalized embryos resulting (<xref ref-type="fig" rid="F6">Fig. 6</xref>). Ectopic mRNA encoding a phosphomimetic CA*Smad1 also strongly ventralizes, even in the presence of <italic>fcho1+2</italic> MOs (<xref ref-type="fig" rid="F6">Fig. 6e-g</xref>). These epistasis-type experiments place Fcho1 within a genetically specified sequence for Bmp signaling (<xref ref-type="fig" rid="F6">Fig. 6n</xref>). Overall, our data imply that Fcho1 positively regulates ventral specification during embryogenesis by bridging Alk8 and the clathrin machinery, consistent with expanded pSmad1/5/8 staining in FCHO1 mRNA-injected embryos.</p>
      </sec>
      <sec id="S9">
        <title>AP-2 loss-of-function</title>
        <p id="P18">FCHO1/2 are argued to be master actuators of endocytosis, remodeling the initial membrane patch and recruiting eps15 and intersectin prior to AP-2<sup><xref rid="R12" ref-type="bibr">12</xref></sup>. If FCHO1/2 are compulsory for clathrin-coated vesicle formation, one testable prediction is that the early dorsalizing effect of <italic>fcho1+2</italic> MOs is wholly reflective of clathrin-mediated endocytosis dysfunction in developing embryos. Like Fcho1/2, in <italic>D. rerio</italic> the AP-2 Î± subunit is encoded by a single gene (<italic>ap2a1</italic>) and is maternally deposited. The transcript is broadly expressed in blastula-, gastrula- and segmentation-stage embryos (<xref ref-type="supplementary-material" rid="SD14">Fig. S7a-c</xref>) like <italic>fcho1/2</italic>.</p>
        <p id="P19">Translation blocking <italic>ap2a1</italic> MO (<xref ref-type="supplementary-material" rid="SD11">Fig. S4</xref>) produces pleomorphic early patterning and axis formation abnormalities and many embryos do not survive to 24 hpf (<xref ref-type="fig" rid="F7">Fig. 7a-e</xref>, <xref ref-type="supplementary-material" rid="SD12">S5</xref>). Phenotypes of surviving morphants at 24 hpf are classified from mild to arrested (<xref ref-type="supplementary-material" rid="SD14">Fig. S7d-i</xref>). In the most severe embryos, the epiboly movement of blastomeres toward the vegetal pole slows and blastopore closure with incomplete epiboly results in dysmorphic bulging of the yolk (<xref ref-type="fig" rid="F7">Fig. 7b, d</xref>). This defect persists beyond bud stage (10 hpf) and yolk rupture typically follows 14-19 hpf (<xref ref-type="fig" rid="F7">Fig. 7d</xref>). Surviving arrested embryos are not developmentally delayed because there is no further morphological progression by 24 hpf (<xref ref-type="supplementary-material" rid="SD13">Fig. S6h</xref>). <italic>ap2a1+p53</italic> MO-coinjected embryos still arrest, while simultaneous injection of the <italic>ap2a1</italic> MO and mouse <italic>ap2a2</italic> mRNA reverts the wild-type morphology (<xref ref-type="fig" rid="F7">Fig. 7f</xref>). A second <italic>ap2a1</italic> and an AP-2 Î¼2-subunit-targeting MO both cause an analogous phenotype. Epiboly arrest may be due, in part, to defective yolk cell endocytosis as the blastoderm margin moves toward the vegetal pole<sup><xref rid="R42" ref-type="bibr">42</xref></sup>. Later, in surviving embryos, ectoderm delaminates and gross morphology is indicative of severe patterning defects (<xref ref-type="fig" rid="F7">Fig. 7l</xref>, <xref ref-type="supplementary-material" rid="SD13">S6f-h</xref>) consistent with the major effect of Î¼<italic>2</italic> MO in early <italic>Xenopus</italic> embryos<sup><xref rid="R43" ref-type="bibr">43</xref></sup>.</p>
        <p id="P20">A survey of standard target genes for early development<sup><xref rid="R35" ref-type="bibr">35</xref></sup> shows serious expression abnormalities. When gastrulation begins Fgf is normally produced from the dorsal organizer and weakly along the margin, but in <italic>ap2a1</italic> (but not <italic>fcho1</italic>) MO embryos <italic>fgf8</italic> transcripts are expanded toward both the ventral and animal poles (<xref ref-type="fig" rid="F7">Fig. 7g-i</xref>). Improper <italic>fgf8</italic> transcription is evident at 30% epiboly (~4.7 hpf). At this stage, there is also precocious hyperactiviation of the phosphatase Dusp6, an Fgf target gene<sup><xref rid="R44" ref-type="bibr">44</xref></sup>. Abnormal and mislocalized production of <italic>dusp6</italic> in <italic>ap2a1</italic> morphants persists to shield stage and, strikingly, expands far beyond the zone of <italic>fgf8</italic> ligand expression. Coinjecting AP-2 Î±-subunit mRNA restores the normal <italic>dusp6</italic> expression pattern (<xref ref-type="fig" rid="F7">Fig. 7j</xref>). Expansion of Fgf signaling range in AP-2 compromised embryos is consistent with endocytosis shaping and maintaining this morphogen gradient in the zebrafish gastrula<sup><xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref></sup>. Clear Fgf signaling and phenotypic differences between <italic>ap2a1</italic> and <italic>fcho1+2+p53</italic> morphants are apparent in live transgenic <italic>Tg(Dusp6:d2EGFP)<sup>pt</sup></italic><sup><xref rid="R6" ref-type="bibr">6</xref></sup> reporter embryos<sup><xref rid="R47" ref-type="bibr">47</xref></sup> at the 6-somite stage (<xref ref-type="fig" rid="F7">Fig. 7k-m</xref>). As the <italic>ap2a1</italic> MO embryos are still round, suppressing AP-2 expression must cause additional cellular/regional defects because Fgf receptor hyperactivation typically induces dorsalization<sup><xref rid="R44" ref-type="bibr">44</xref>,<xref rid="R48" ref-type="bibr">48</xref></sup>. Importantly, the GFP reporter rules out that abnormal activation of Fgf signaling underlies the <italic>fcho1</italic> MO dorsalization.</p>
        <p id="P21">Other body plan patterning pathways are anomalous in <italic>ap2a1</italic>-silenced embryos when gastrulation starts: distribution of <italic>chordin, bmp4, bozozok</italic>, <italic>goosecoid</italic>, <italic>and squint</italic> transcripts is abnormal (<xref ref-type="fig" rid="F7">Fig. 7n-p</xref>). Thus, AP-2 appears to function generally in multiple developmental pathways during early development as seriously defective body patterning information results without a functional adaptor. Because the effect on transducing Fgf and other inductive signals in <italic>ap2a1</italic> morphants is distinct from how <italic>fcho1+2</italic> MO alters the fate map, we conclude AP-2 function is not invariably dependent on upstream Fcho1/2 during embryogenesis.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S10">
      <title>DISCUSSION</title>
      <p id="P22">Proper embryonic patterning depends on precise temporal integration of spatially complex signaling events. Endocytosis modulates signaling by constantly adjusting surface protein abundance<sup><xref rid="R49" ref-type="bibr">49</xref></sup> and here we show that this process is vital for zebrafish development. Our results are consistent with Fcho1 operating with Alk8 and Bmp2bâBmp7 heterodimers to signal ventral fates. Because FCHO1/2 are incontestably clathrin-coat constituents, the simplest model is that clathrin-mediated endocytosis promotes Bmp signaling. The precise basis for this remains to be elucidated; one possibility is that Fcho1/2 with Alk8 shapes the ventral Bmp gradient, as does type I BMP receptor Thick veins in <italic>Drosophila</italic><sup><xref rid="R50" ref-type="bibr">50</xref></sup>. Thick veins, the <italic>Drosophila</italic> Decapentaplegic receptor, binds directly to another intersectin-binding EFC domain protein, Nervous wreck<sup><xref rid="R51" ref-type="bibr">51</xref></sup>. Yet Nervous wreck has a C-terminal SH3 domain substituted for the Î¼HD, so the basis for the interaction cannot be structurally similar, and, critically, the consequence of the association is negative feedback on Decapentaplegic signaling. It thus appears remote that muniscins govern routing of Alk8 receptors to lysosomes because Fcho1 positively modulates Bmp signaling in zebrafish embryos.</p>
      <p id="P23">Receptors can require prior internalization and recycling to gain signaling competence<sup><xref rid="R52" ref-type="bibr">52</xref></sup>. Another possibility then is that by promoting uptake of uncomplexed type I receptors (Alk8), the level of type IâII functional heterodimers is optimized. Alternatively, Fcho1 could be involved in forming Bmp gradients by decreasing available receptor/ligand in dorsally positioned cells, but that would give rise to ventralization, not dorsalization, upon MO injection. More likely, clathrin-mediated endocytosis provides access to an endosomal signaling station for cytosolic propagation and refinement of the Bmp signal. Spatial separation between TGF-Î²/BMP receptor activation at the plasma membrane and signal propagation from endosomes is apparent<sup><xref rid="R53" ref-type="bibr">53</xref>,<xref rid="R54" ref-type="bibr">54</xref></sup>. In cultured cells, the extent of activin-triggered Smad phosphorylation decreases when internalization is blocked<sup><xref rid="R55" ref-type="bibr">55</xref></sup>. Optimal phosphorylation of R-Smads by TGF-Î² receptors requires SARA, an endosome-associated PtdIns3P-binding protein<sup><xref rid="R56" ref-type="bibr">56</xref>-<xref rid="R59" ref-type="bibr">59</xref></sup>. The R-Smad binding FYVE domain protein Endofin plays an analogous role during BMP signaling<sup><xref rid="R60" ref-type="bibr">60</xref></sup>. Fcho1 could drive the delivery of Alk8 to endosomes for an encounter with Endofin then.</p>
      <p id="P24">Zebrafish are characterized by very rapid developmental progression; tissue specific cell clones are evident during gastrulation (&gt;6 hpf) and a recognizable body plan and differentiating organs apparent before 12 hpf<sup><xref rid="R61" ref-type="bibr">61</xref></sup>. Perhaps Fcho1/2 has been previously missed because the time constraints for signal propagation in other systems are dissimilar to <italic>D. rerio</italic> early development. An association between FCHO1 and ACVR1, the mammalian Alk8 ortholog, has been mapped by high-throughput affinity-capture proteomics<sup><xref rid="R62" ref-type="bibr">62</xref></sup>. Another hallmark of zebrafish embryogenesis is brisk and expansive cell movements. Maximal signal transmission from an endosomal extension of the cell surface may allow proper âmemoryâ signaling in cells that have moved away from the initial, fate-determining morphogen gradient<sup><xref rid="R63" ref-type="bibr">63</xref></sup>.</p>
      <p id="P25">On the basis of MOs recapitulating maternal effect phenotypes<sup><xref rid="R33" ref-type="bibr">33</xref></sup> it is clear the translational silencing approach ablates maternal gene expression. Why then are <italic>fcho1</italic>, <italic>fcho2</italic> and <italic>ap2a1</italic> morphants not more severely affected? Targeted gene disruption of the AP-2 Î¼2 subunit is lethal<sup><xref rid="R64" ref-type="bibr">64</xref></sup> but <italic>ap2a1</italic> MO in zebrafish allows visualization of early embryonic processes prior to dysmorphic arrest due to protein insufficiency. This is because MO-based silencing cannot obstruct maternally deposited protein. Substantial clathrin coat machinery must be provisioned in the oocyte as massive cortical granule exocytosis following fertilization is balanced by compensatory clathrin-dependent endocytosis<sup><xref rid="R65" ref-type="bibr">65</xref></sup>. Clathrin-coated buds are also seen at the cleavage furrow during the initial rounds of cell division following fertilization<sup><xref rid="R66" ref-type="bibr">66</xref></sup>. Still, an early and severe developmental defect on <italic>ap2a1</italic> silencing is fully consistent with AP-2 Î¼2 subunit morphants in <italic>Xenopus</italic><sup><xref rid="R43" ref-type="bibr">43</xref></sup>. Strikingly the phenotypic outcome of extinguishing AP-2 or Fcho1/2 transcripts is not identical. If Fcho1/2 are obligatory for the nucleation of endocytic clathrin coats, this is unexpected. One possibility is that the perdurance of the muniscins is greater than the AP-2 heterotetramer in early embryos. However, simultaneous RNAi silencing of both FCHO1 and FCHO2 in neither HeLa nor BS-C-1 cells causes loss of AP-2-positive clathrin-coated structures at the cell surface (<xref ref-type="fig" rid="F8">Fig. 8</xref>). This is fully consistent with the very mild phenotype in <italic>syp1Î</italic> yeast<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup>.</p>
      <p id="P26">The structure, dynamics<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R67" ref-type="bibr">67</xref></sup> and extensive interactions shared by FCHO1 and FCHO2 suggest muniscins advance clathrin endocytosis. This may explain the weak additive effect of <italic>fcho2</italic> MO on the <italic>fcho1</italic> morphant phenotype, reflecting a degree of functional overlap between the paralogues. If part of a pioneer module<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup>, how do clathrin coats persist without these factors? A topological feature of the clathrin interactome is redundancy<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup>. Surplus connections make the network tolerant to perturbations; AP-2 can be largely extinguished in cultured cells but rapid uptake of certain cargo continues<sup><xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>. As the Î¼HD engages other pioneer scaffolds (<xref ref-type="fig" rid="F2">Fig. 2h</xref>) collective establishment of this preponderance of links, even without Fcho1/2, permits positioning of AP-2 at the first encounter zone of a bud site. Cargo selective defects are instead manifest, highlighting that all known Î¼HD-bearing proteins are involved in gathering cargo<sup><xref rid="R15" ref-type="bibr">15</xref></sup>.</p>
    </sec>
    <sec sec-type="methods" id="S11">
      <title>METHODS</title>
      <sec id="S12">
        <title>Molecular cloning and constructs</title>
        <p id="P27">The human <italic>FCHO1, FCHO2</italic>, mouse <italic>Fcho2</italic> and zebrafish <italic>Fcho2</italic> cDNA clones were obtained from Open Biosystems. The sequences encoding full-length <italic>FCHO1</italic>, <italic>FCHO1</italic> (1-609), <italic>FCHO1</italic> (267-609), <italic>FCHO1</italic> (442-609), <italic>FCHO1</italic> Î¼HD (609-889), full-length <italic>Fcho2</italic> and <italic>Fcho2</italic> Î¼HD (527-809) were PCR amplified and cloned into pEGFP-C1 or pGEX-4T-1 for expression of either an N-terminal GFP or GST fusion protein. The full-length human <italic>FCHO1</italic>, <italic>FCHO1</italic> (1-609) and zebrafish <italic>fcho2</italic> were similarly cloned into pCS2+ for mRNA synthesis or transient transfections. Stop codons were introduced at appropriate sites using QuikChange (Stratagene) site-directed mutagenesis to construct FCHO1 (1-275), FCHO1 (1-609), Fcho2 (1-302) and the various other truncation mutants described in the text. The GST-Î²2 appendage (rat residues 701-937), GST-Î±<sub>C</sub> appendage (mouse residues 701-938), GST-eps15 (595-896) and GST-ARH constructs have been described previously<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R68" ref-type="bibr">68</xref></sup>. The 25-bp regions at the 5â² end of zebrafish <italic>fcho1</italic>, <italic>fcho2</italic> and <italic>ap2a1</italic> used to design antisense morpholinos were cloned in-frame into pCS2-GFP-N1 to generate respective 5â²MO-GFP constructs that were subsequently used to test the effectiveness of translational silencing by <italic>fcho1</italic>, <italic>fcho2</italic> and <italic>ap2a1</italic> MOs <italic>in vivo</italic>. The coding sequence of the zebrafish <italic>fcho1</italic> Î¼HD with flanking 5â² and 3â² regions was first amplified by RT-PCR from 1,000-cell stage zebrafish embryonic cDNA using a set of PCR primers designed from EST clones encoding the 5â² (GenBank accession AL920021) or the 3â² (GenBank AL921007) ends of the Î¼HD. Then, the complete coding sequence of the Î¼HD was PCR amplified from the RT-PCR product and cloned into pGEX-4T-1. The pCS2-<italic>alk8</italic>, pCS2-<italic>bmp2b</italic> and pCS2-<italic>bmp7</italic> plasmids<sup><xref rid="R13" ref-type="bibr">13</xref></sup> were kindly provided by Dr. Mary Mullins while the pCS2-CA*<italic>smad1</italic> construct (<sup>470</sup>SVS of zebrafish Smad1 mutated to <sup>470</sup>DVD ) was a gift from Dr. Beth Roman. The <italic>alk8</italic> coding sequence was PCR amplified from pCS2-<italic>alk8</italic> and subcloned into the pCS2-myc<sub>6</sub> vector to obtain pCS2-<italic>alk8</italic>-myc<sub>6</sub>. A Q204D mutation yielded the CA*Alk8. All constructs were sequence-verified and full details of plasmids and primers (Integrated DNA Technologies) are available upon request.</p>
      </sec>
      <sec id="S13">
        <title>RT-PCR and 5â² RACE</title>
        <p id="P28">Total RNA (5 Î¼g) extracted from embryos at different developmental stages using TRIZOL method (Invitrogen) was used as template for cDNA preparation. cDNA was generated using an oligo-(dT) primer and Thermoscript reverse transcriptase (Invitrogen) according to the manufacturerâs directions. Subsequently, the cDNA was amplified with gene specific primers for <italic>fcho1</italic>, <italic>fcho2</italic>, and <italic>ap2a1</italic> (as listed in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Table</xref>). Î² actin primers were used as an internal control for the quality of cDNA synthesis. The amplified DNA was subjected to agarose gel electrophoresis and exon-specific bands identified both by size and by sequencing. 5â² RACE was performed by standard procedures (Invitrogen). Total RNA from 1-cell and 1,000-cell stage embryos was reverse transcribed to cDNA using an antisense gene specific primer (GSP1) near the 5â² end. The template cDNA was tailed at 3â² end using dCTP and terminal deoxynucleotidyl transferase (New England Biolabs). The tailed cDNA was PCR amplified with a set composed of a 5â² RACE anchor adaptor primer and a second antisense gene specific primer (GSP2). The primer sequences used for 5â² RACE are provided in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Table</xref>. The amplicon was purified, confirmed by sequencing and the sequence deposited in GenBank (Accession number JN412732) at the NCBI.</p>
      </sec>
      <sec id="S14">
        <title>Antibodies</title>
        <p id="P29">The affinity-purified rabbit anti-FCHO1 antibody 1 (1:2,500), anti-FCHO2 (1:2,500), anti-Dab2 (1:1,000), anti-epsin 1 (1:10,000) and anti-AP-1/2 Î²1/Î²2-subunit GD/1 (1:2,500) antibodies were produced commercially for our laboratory. A second affinity-purified anti-FCHO2 (1:2500) antibody was kindly provided by Dr. Harvey McMahon. Affinity-purified rabbit anti-eps15 polyclonal antibody was a gift from Dr. Ernst Ungewickell, the anti-clathrin HC mAbs TD.1 (1:5,000) and X22 and the anti-AP-2 Î±-subunit mAb AP.6 were generously provided by Dr. Frances Brodsky, the anti-CALM mAb (1:1,000) kindly provided by Dr. Jeong-Ah Kim, rabbit R11-29 anti-AP-2 Î¼2-subunit (1:3,000) antiserum kindly provided by Dr. Juan Bonifacino and the rabbit anti-intersectin 1 (1:2,000) antibody a gift from Dr. Peter McPherson. The affinity-purified rabbit anti-APPL1 (1:50) was kindly provided by Dr. David Kaplan. The goat anti-Hrb C-19 (1:1000; sc-1424), rabbit anti-eps15 C-20 (1:500; sc-534) polyclonal antibodies and rabbit anti-SHIP2 mAb E-2 (1:500; sc-166641) from Santa Cruz Biotechnology, rabbit anti-eps15R (1:5,000; EP-1145Y) antibody and rabbit anti-FCHO1 antibody 2 (1:1,000; ab84740) from Abcam, and the mouse anti-myc mAb 9E10 (1: 1,000; MMS-150P) from Covance were used. The anti-Î²-tubulin mAb E7 (1:2,500) was purchased from the DSHB, mAbs directed against the AP-2 Î± subunit clone 8/Adaptin Î± (1:1,000; 610502), AP180 clone 34 (1:250; A41820), amphiphysin I clone 15 (1:5,000; A59420), EEA1 clone C14/EEA1 (1:250; 610457) and intersectin clone 29 (1:250; 611574) were from BD Transduction Laboratories. The secondary antibodies used were donkey anti-rabbit (1:5,000; NA934V) or anti-mouse (1:5,000; NA931V) horseradish peroxidase conjugates from GE Healthcare or rabbit anti-goat (1:5,000; A4174) peroxidase conjugate from Sigma.</p>
      </sec>
      <sec id="S15">
        <title>Cell culture and transfections</title>
        <p id="P30">HeLa SS6 cells were cultured in DMEM supplemented with 10% fetal calf serum and 2 mM L-glutamine at 37Â°C in an atmosphere of 5% CO<sub>2</sub>. BS-C-1 cells stably expressing GFP-tagged clathrin light chain a were generously provided by Tomas Kirchhausen. The BS-C-1 cells were similarly grown in DMEM, 10% fetal calf serum, 2 mM L-glutamine supplemented with 0.4 mg/ml G418. Cells were routinely transfected with plasmids using Lipofectamine 2000 (Invitrogen) or siRNA oligonucleotides (listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table</xref>) using Oligofectamine (Invitrogen) according to the manufacturerâs instructions. For all RNAi treatments, cells were transfected twice, normally 48 h apart and with reseeding the cells before the second siRNA application, at which time the relevant transiently transfected plasmid was also included. Typically, 18-24 h after the second transfection, cells were fixed with 4% paraformaldehyde, blocked and permeabilized in 10% normal goat serum, 0.2% saponin in PBS. For transferrin binding and uptake assays, cells were incubated in DMEM, 25 mM Hepes, 0.5% BSA for 1 h at 37Â°C to remove bound transferrin. Alternatively, lysates from parental HeLa cells or HeLa cells expressing (from pCS2+) full-length (1-889) or truncated (1-609) <italic>H. sapiens</italic> FCHO1, or myc-tagged WT Alk8 or CA*Alk8 were prepared from transiently-transfected (24-48 h) cells collected by trypsinization. After washing, cell pellets were solubilized on ice for 30 min in 25 mM Hepes-KOH (pH 7.2), 125 mM potassium acetate, 5 mM magnesium acetate, 2 mM EDTA, 2mM EGTA, and 2 mM dithiothreitol (assay buffer) supplemented with 1% Triton X-100, 1 mM PMSF and Complete protease inhibitor cocktail (Roche). Lysates were centrifuged at 20,000 X <italic>g</italic><sub>max</sub> before use in binding assays.</p>
      </sec>
      <sec id="S16">
        <title>Zebrafish maintenance, morpholinos and mRNA injections</title>
        <p id="P31">The Oregon AB* and <italic>Tg(Dusp6:d2EGFP)<sup>pt6</sup></italic> strains were maintained under standard conditions at the University of Pittsburgh School of Medicine in accordance with Institutional and Federal guidelines for use, care and maintenance of experimental animal models and with University of Pittsburgh Institutional Animal Care and Use Committee (IACUC) approval. Embryos from natural matings were obtained and developmentally staged<sup><xref rid="R61" ref-type="bibr">61</xref></sup>. The sequence of the various morpholinos used in this study, custom synthesized by Gene Tools, are listed in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Table</xref>. The translation-blocking ATG specific <italic>fcho1</italic> morpholino was designed on the basis of the authentic 5â² sequence of zebrafish embryonic <italic>fcho1</italic> transcript mapped by 5â² RACE. A standard control MO and <italic>p53</italic> MO was obtained from Gene Tools as detailed elsewhere<sup><xref rid="R69" ref-type="bibr">69</xref></sup>. The desired concentrations of the appropriate morpholinos were microinjected at 5 nl/embryo into the yolk at 1- to 2-cell stage. Capped mRNAs for misexpression and rescue experiments were transcribed <italic>in vitro</italic> from linearized pCS2+ constructs using SP6 mMessage mMachine kit (Ambion) and microinjected at 1 nl into the blastomere at 1-cell stage. After injections, the embryos were incubated in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl<sub>2</sub>, 0.33 mM MgSO<sub>4</sub>, 0.01% methylene blue) at 28Â°C until the desired stage.</p>
      </sec>
      <sec id="S17">
        <title>Whole-mount <italic>in situ</italic> hybridization and immunofluorescence</title>
        <p id="P32">The EST clones for <italic>fcho1</italic> (GenBank AL920021) and <italic>ap2a1</italic> (GenBank AL920300) in pBluescript SK+ were obtained from Open Biosystems, linearized and directly used for riboprobe synthesis. For <italic>fcho2</italic>, an 880-bp fragment encoding the C-terminal end was PCR amplified (using <italic>fcho2</italic> T7 sense and antisense primers) from the zebrafish <italic>fcho2</italic> EST clone (GenBank BC095680). All other probes used in this study (no tail, sonic hedgehog, bmp4, chordin, krox20, gata1, goosecoid, bozozok, squint, fgf8, fgfR1 and <italic>dusp6</italic>) were made similarly by linearizing corresponding vectors containing a T7 RNA polymerase promoter, using appropriate restriction enzymes as described elsewhere<sup><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R69" ref-type="bibr">69</xref></sup>. Riboprobe synthesis for <italic>in situ</italic> hybridization was performed using DIG RNA labeling mix and T7 RNA polymerase (Roche) according to the manufacturerâs recommendations. Zebrafish embryos at appropriate developmental stages were fixed in 4% paraformaldehyde at 4Â°C overnight, washed once in PBS and stored in methanol at -20Â°C. Whole-mount <italic>in situ</italic> hybridizations were performed by standard procedures<sup><xref rid="R69" ref-type="bibr">69</xref></sup>. Embryos were washed several times in PBS and mounted in glycerol. Alternatively, live embryos, either within or removed from the chorion, were mounted in 3% methylcellulose and overlaid with E3 containing 0.016% tricaine (pH 7.0). Oriented embryos were viewed using a Leica MZ16FA stereo fluorescence microscope with a 1x (NA 0.14) objective and bright field or fluorescence images collected with a QImaging Retiga-EXi Fast 1394 digital camera.</p>
        <p id="P33">For immunofluorescence, embryos fixed overnight in 4% paraformaldehyde at 4Â°C, were permeabilized in 1% Triton-X-100, blocked in 10% sheep serum, 1% DMSO, 0.1% Triton X-100 in PBS and probed overnight with rabbit anti-phosphoSmad (pSmad) 1/5/8 (1:100; 9511) from Cell Signaling Technology or GD/1 (1:100) antibody. The immunizing peptide for the GD/1 antibody (GDLLNLLGPPV) is 100% conserved in the <italic>D. rerio</italic> AP-2 Î²2 subunit (<italic>ap2b1</italic>). Primary antibodies were followed with goat anti-rabbit Alexa488-or Cy5-conjugated antibody (1:500; Molecular Probes) and Hoechst 33258 nuclear stain before mounting for confocal microscopy. For GFP-FCHO1/AP-2 immunofluorescence, embryos at 5 hpf were embedded in 1% low melting point agarose in E3 medium on poly-D-lysine coated dishes (MatTek) with the animal pole oriented toward the glass bottom. For pSmad 1/5/8 immunofluorescence, embryos at 7 hpf were embedded with dorsal shield side toward the right. Images were acquired on an Olympus Fluoview1000 confocal microscope using an UplanSapo 20X (NA 0.75) or an UPlanFLN 40X (NA 1.3) oil objective. Data was acquired using the FV10-ASW software. Similar procedures were used for immunofluorescence analysis of cultured mammalian cells.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="SM">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>1</label>
        <media xlink:href="NIHMS360591-supplement-1.xls" mimetype="application" mime-subtype="vnd.ms-excel" orientation="portrait" xlink:type="simple" id="d37e1437" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD10">
        <label>5</label>
        <media xlink:href="NIHMS360591-supplement-5.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1441" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD11">
        <label>6</label>
        <media xlink:href="NIHMS360591-supplement-6.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1445" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD12">
        <label>7</label>
        <media xlink:href="NIHMS360591-supplement-7.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1449" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD13">
        <label>8</label>
        <media xlink:href="NIHMS360591-supplement-8.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1453" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD14">
        <label>9</label>
        <media xlink:href="NIHMS360591-supplement-9.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1457" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>10</label>
        <media xlink:href="NIHMS360591-supplement-10.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" xlink:type="simple" id="d37e1461" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>11</label>
        <media xlink:href="NIHMS360591-supplement-11.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" xlink:type="simple" id="d37e1465" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>12</label>
        <media xlink:href="NIHMS360591-supplement-12.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" xlink:type="simple" id="d37e1469" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD5">
        <label>13</label>
        <media xlink:href="NIHMS360591-supplement-13.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" xlink:type="simple" id="d37e1473" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD6">
        <label>14</label>
        <media xlink:href="NIHMS360591-supplement-14.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" xlink:type="simple" id="d37e1478" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD7">
        <label>2</label>
        <media xlink:href="NIHMS360591-supplement-2.doc" mimetype="application" mime-subtype="msword" orientation="portrait" xlink:type="simple" id="d37e1482" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD8">
        <label>3</label>
        <media xlink:href="NIHMS360591-supplement-3.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1486" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD9">
        <label>4</label>
        <media xlink:href="NIHMS360591-supplement-4.ai" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d37e1490" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S18">
      <title>Acknowledgements</title>
      <p>We are indebted to our many gracious colleagues for generously providing important reagents that were essential for this study. Supported by NIH grants R01 HL088016 (MT) and R01 GM60979 (BW) and R01 DK53249 (LMT).</p>
    </ack>
    <fn-group>
      <fn id="FN1">
        <p id="P34"><bold>Contributions</bold> P.K.U., S.S., J.R.T., S.C., L.M.T. designed, performed and interpreted various experiments. B.W. and M.T. provided intellectual input, contributed to experimental design and advised on data interpretation. L.M.T. conceived and directed the overall project and wrote the manuscript with comments from all the authors.</p>
      </fn>
      <fn id="FN2">
        <p id="P35"><bold>Competing financial interests</bold> The authors declare no competing financial interests.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conner</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Regulated portals of entry into the cell</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>422</volume>
          <fpage>37</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">12621426</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMahon</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Boucrot</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanism and physiological functions of clathrin-mediated endocytosis</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>517</fpage>
          <lpage>533</lpage>
          <comment>doi:nrm3151 [pii] 10.1038/nrm3151</comment>
          <pub-id pub-id-type="pmid">21779028</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirchhausen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Imaging endocytic clathrin structures in living cells</article-title>
          <source>Trends Cell Biol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>596</fpage>
          <lpage>605</lpage>
          <comment>doi:S0962-8924(09)00192-5 [pii] 10.1016/j.tcb.2009.09.002</comment>
          <pub-id pub-id-type="pmid">19836955</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelly</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Endocytic sorting of transmembrane protein cargo</article-title>
          <source>Curr Opin Cell Biol</source>
          <year>2011</year>
          <comment>doi:S0955-0674(11)00021-4 [pii] 10.1016/j.ceb.2011.03.004</comment>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reider</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wendland</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Endocytic adaptors - social networking at the plasma membrane</article-title>
          <source>J Cell Sci</source>
          <year>2011</year>
          <volume>124</volume>
          <fpage>1613</fpage>
          <lpage>1622</lpage>
          <comment>doi:124/10/1613 [pii] 10.1242/jcs.073395</comment>
          <pub-id pub-id-type="pmid">21536832</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traub</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Tickets to ride: selecting cargo for clathrin-regulated internalization</article-title>
          <source>Nat. Rev. Mol. Cell Biol</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>583</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">19696796</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Perrais</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Merrifield</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>A high precision survery of the molecular dynamics of mammalian clathrin mediated endocytosis</article-title>
          <source>PLoS Biol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>e1000604</fpage>
          <pub-id pub-id-type="pmid">21445324</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>HT</given-names>
            </name>
          </person-group>
          <article-title>Integrating molecular and network biology to decode endocytosis</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>448</volume>
          <fpage>883</fpage>
          <lpage>888</lpage>
          <pub-id pub-id-type="pmid">17713526</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boucrot</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Saffarian</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Massol</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kirchhausen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ehrlich</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Role of lipids and actin in the formation of clathrin-coated pits</article-title>
          <source>Exp. Cell Res</source>
          <year>2006</year>
          <volume>312</volume>
          <fpage>4036</fpage>
          <lpage>4048</lpage>
          <pub-id pub-id-type="pmid">17097636</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoncu</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of endocytic clathrin-coated pits upon acute depletion of phosphatidylinositol 4,5-bisphosphate</article-title>
          <source>Proc. Natl. Acad. Sci. U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>3793</fpage>
          <lpage>3798</lpage>
          <pub-id pub-id-type="pmid">17360432</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>LP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex</article-title>
          <source>Cell</source>
          <year>2010</year>
          <volume>141</volume>
          <fpage>1220</fpage>
          <lpage>1229</lpage>
          <comment>doi:S0092-8674(10)00542-8 [pii] 10.1016/j.cell.2010.05.006</comment>
          <pub-id pub-id-type="pmid">20603002</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henne</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FCHo proteins are nucleators of clathrin-mediated endocytosis</article-title>
          <source>Science</source>
          <year>2010</year>
          <volume>328</volume>
          <comment>doi:science.1188462 [pii] 10.1126/science.1188462</comment>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Little</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis</article-title>
          <source>Nat. Cell Biol</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>637</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="pmid">19377468</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mintzer</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lost-a-fin encodes a type I BMP receptor, Alk8, acting maternally and zygotically in dorsoventral pattern formation</article-title>
          <source>Development</source>
          <year>2001</year>
          <volume>128</volume>
          <fpage>859</fpage>
          <lpage>869</lpage>
          <pub-id pub-id-type="pmid">11222141</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reider</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Syp1 is a conserved endocytic adaptor that contains domains involved in cargo selection and membrane tubulation</article-title>
          <source>EMBO J</source>
          <year>2009</year>
          <volume>28</volume>
          <fpage>3103</fpage>
          <lpage>3016</lpage>
          <pub-id pub-id-type="pmid">19713939</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katoh</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of human FCHO2 and mouse Fcho2 genes in silico</article-title>
          <source>Int. J. Mo.l Med</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>327</fpage>
          <lpage>331</lpage>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stimpson</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Toret</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Pauly</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Drubin</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Early-arriving Syp1p and Ede1p function in endocytic site placement and formation in budding yeast</article-title>
          <source>Mol. Biol. Cell</source>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boettner</surname>
              <given-names>DR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The F-BAR protein Syp1 negatively regulates WASp-Arp2/3 complex activity during endocytic patch formation</article-title>
          <source>Curr. Biol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>1979</fpage>
          <lpage>1987</lpage>
          <pub-id pub-id-type="pmid">19962315</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uezu</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of the EFC/F-BAR domain protein, FCHO2</article-title>
          <source>Genes Cells</source>
          <year>2011</year>
          <comment>doi:10.1111/j.1365-2443.2011.01536.x</comment>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoncu</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes</article-title>
          <source>Cell</source>
          <year>2009</year>
          <volume>136</volume>
          <fpage>1110</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="pmid">19303853</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henne</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature</article-title>
          <source>Structure</source>
          <year>2007</year>
          <volume>15</volume>
          <fpage>839</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="pmid">17540576</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edeling</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Life of a clathrin coat: insights from clathrin and AP structures</article-title>
          <source>Nat. Rev. Mol. Cell Biol</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>32</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">16493411</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edeling</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular switches involving the AP-2 Î²2 appendage regulate endocytic cargo selection and clathrin coat assembly</article-title>
          <source>Dev. Cell</source>
          <year>2006</year>
          <volume>10</volume>
          <fpage>329</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">16516836</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid</surname>
              <given-names>EM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of the AP2 Î²-appendage hub in recruiting partners for clathrin coated vesicle assembly</article-title>
          <source>PLoS Biol</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>e262</fpage>
          <pub-id pub-id-type="pmid">16903783</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mishra</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual-engagement regulation of protein interactions with the AP-2 adaptor Î± appendage</article-title>
          <source>J. Biol. Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>46191</fpage>
          <lpage>46203</lpage>
          <pub-id pub-id-type="pmid">15292237</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Praefcke</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolving nature of the AP2 Î±-appendage hub during clathrin-coated vesicle endocytosis</article-title>
          <source>EMBO J</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>4371</fpage>
          <lpage>4383</lpage>
          <pub-id pub-id-type="pmid">15496985</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinrichsen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harborth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Andrees</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ungewickell</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Effect of clathrin heavy chain- and Î±-adaptin specific small interfering RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells</article-title>
          <source>J. Biol. Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>45160</fpage>
          <lpage>45170</lpage>
          <pub-id pub-id-type="pmid">12960147</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motley</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bright</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Seaman</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Clathrin-mediated endocytosis in AP-2-depleted cells</article-title>
          <source>J. Cell Biol</source>
          <year>2003</year>
          <volume>162</volume>
          <fpage>909</fpage>
          <lpage>918</lpage>
          <pub-id pub-id-type="pmid">12952941</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uezu</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SGIP1Î± is an endocytic protein that directly interacts with phospholipids and Eps15</article-title>
          <source>J. Biol. Chem</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>26481</fpage>
          <lpage>26489</lpage>
          <pub-id pub-id-type="pmid">17626015</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamabhai</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains</article-title>
          <source>J. Biol. Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>31401</fpage>
          <lpage>31407</lpage>
          <pub-id pub-id-type="pmid">9813051</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koh</surname>
              <given-names>TW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Eps15 and Dap160 control synaptic vesicle membrane retrieval and synapse development</article-title>
          <source>J. Cell Biol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>309</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">17620409</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sengar</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bishay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>The EH and SH3 domain Ese proteins regulate endocytosis by linking to dynamin and Eps15</article-title>
          <source>EMBO J</source>
          <year>1999</year>
          <volume>18</volume>
          <fpage>1159</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="pmid">10064583</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Talbot</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Morpholino phenocopies of the bmp2b/swirl and bmp7/snailhouse mutations</article-title>
          <source>Genesis</source>
          <year>2001</year>
          <volume>30</volume>
          <fpage>160</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">11477698</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mullins</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes</article-title>
          <source>Development</source>
          <year>1996</year>
          <volume>123</volume>
          <fpage>81</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">9007231</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schier</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Talbot</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Molecular genetics of axis formation in zebrafish</article-title>
          <source>Annu. Rev. Genet</source>
          <year>2005</year>
          <volume>39</volume>
          <fpage>561</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="pmid">16285872</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tucker</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Mintzer</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>The BMP signaling gradient patterns dorsoventral tissues in a temporally progressive manner along the anteroposterior axis</article-title>
          <source>Dev Cell</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>108</fpage>
          <lpage>119</lpage>
          <comment>doi:S1534-5807(07)00424-8 [pii] 10.1016/j.devcel.2007.11.004</comment>
          <pub-id pub-id-type="pmid">18194657</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robu</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>p53 activation by knockdown technologies</article-title>
          <source>PLoS Genet</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>e78</fpage>
          <pub-id pub-id-type="pmid">17530925</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulte-Merker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The zebrafish organizer requires chordino</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>387</volume>
          <fpage>862</fpage>
          <lpage>863</lpage>
          <comment>doi:10.1038/43092</comment>
          <pub-id pub-id-type="pmid">9202118</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von der Hardt</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Bmp gradient of the zebrafish gastrula guides migrating lateral cells by regulating cell-cell adhesion</article-title>
          <source>Curr. Biol</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>475</fpage>
          <lpage>487</lpage>
          <pub-id pub-id-type="pmid">17331724</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lele</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rauch</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Geisler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The type I serine/threonine kinase receptor Alk8/Lost-a-fin is required for Bmp2b/7 signal transduction during dorsoventral patterning of the zebrafish embryo</article-title>
          <source>Development</source>
          <year>2001</year>
          <volume>128</volume>
          <fpage>849</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="pmid">11222140</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Payne</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Postlethwait</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Yelick</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Functional characterization and genetic mapping of alk8</article-title>
          <source>Mech. Dev</source>
          <year>2001</year>
          <volume>100</volume>
          <fpage>275</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">11165484</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solnica-Krezel</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Gastrulation in zebrafish â all just about adhesion?</article-title>
          <source>Curr. Opin. Genet. Dev</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>433</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="pmid">16797963</pub-id>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borner</surname>
              <given-names>GH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CVAK104 is a novel regulator of clathrin-mediated SNARE sorting</article-title>
          <source>Traffic</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>893</fpage>
          <lpage>903</lpage>
          <comment>doi:TRA576 [pii] 10.1111/j.1600-0854.2007.00576.x</comment>
          <pub-id pub-id-type="pmid">17587408</pub-id>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsang</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A role for MKP3 in axial patterning of the zebrafish embryo</article-title>
          <source>Development</source>
          <year>2004</year>
          <volume>131</volume>
          <fpage>2769</fpage>
          <lpage>2779</lpage>
          <pub-id pub-id-type="pmid">15142973</pub-id>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>SR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules</article-title>
          <source>Nature</source>
          <year>2009</year>
          <volume>461</volume>
          <fpage>533</fpage>
          <lpage>536</lpage>
          <pub-id pub-id-type="pmid">19741606</pub-id>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scholpp</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Endocytosis controls spreading and effective signaling range of Fgf8 protein</article-title>
          <source>Curr. Bio.l</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>1834</fpage>
          <lpage>1841</lpage>
          <comment>doi:S0960982204007481 [pii] 10.1016/j.cub.2004.09.084</comment>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molina</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Tsang</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Generation of FGF reporter transgenic zebrafish and their utility in chemical screens</article-title>
          <source>BMC Dev. Biol</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>62</fpage>
          <pub-id pub-id-type="pmid">17553162</pub-id>
        </element-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furthauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Van Celst</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thisse</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Thisse</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Fgf signalling controls the dorsoventral patterning of the zebrafish embryo</article-title>
          <source>Development</source>
          <year>2004</year>
          <volume>131</volume>
          <fpage>2853</fpage>
          <lpage>2864</lpage>
          <comment>doi:10.1242/dev.01156 dev.01156 [pii]</comment>
          <pub-id pub-id-type="pmid">15151985</pub-id>
        </element-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorkin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>von Zastrow</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Endocytosis and signalling: intertwining molecular networks</article-title>
          <source>Nat. Rev. Mol. Cell Biol</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>609</fpage>
          <lpage>922</lpage>
          <pub-id pub-id-type="pmid">19696798</pub-id>
        </element-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belenkaya</surname>
              <given-names>TY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans</article-title>
          <source>Cell</source>
          <year>2004</year>
          <volume>119</volume>
          <fpage>231</fpage>
          <lpage>244</lpage>
          <comment>doi:S0092867404009390 [pii] 10.1016/j.cell.2004.09.031</comment>
          <pub-id pub-id-type="pmid">15479640</pub-id>
        </element-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>OâConnor-Giles</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Ganetzky</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Nervous wreck interacts with thickveins and the endocytic machinery to attenuate retrograde BMP signaling during synaptic growth</article-title>
          <source>Neuron</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>507</fpage>
          <lpage>518</lpage>
          <pub-id pub-id-type="pmid">18498733</pub-id>
        </element-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Struhl</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Distinct roles for Mind bomb, Neuralized and Epsin in mediating DSL endocytosis and signaling in Drosophila</article-title>
          <source>Development</source>
          <year>2005</year>
          <volume>132</volume>
          <fpage>2883</fpage>
          <lpage>2894</lpage>
          <pub-id pub-id-type="pmid">15930117</pub-id>
        </element-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hartung</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling</article-title>
          <source>Mol Cell Biol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>7791</fpage>
          <lpage>7805</lpage>
          <comment>doi:MCB.00022-06 [pii] 10.1128/MCB.00022-06</comment>
          <pub-id pub-id-type="pmid">16923969</pub-id>
        </element-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heining</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bhushan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Paarmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Henis</surname>
              <given-names>YI</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Spatial segregation of BMP/Smad signaling affects osteoblast differentiation in C2C12 cells</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e25163</fpage>
          <comment>doi:10.1371/journal.pone.0025163 PONE-D-11-09166 [pii]</comment>
          <pub-id pub-id-type="pmid">21998639</pub-id>
        </element-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Receptor internalization-independent activation of Smad2 in activin signaling</article-title>
          <source>Mol. Endocrinol</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>1818</fpage>
          <lpage>1826</lpage>
          <pub-id pub-id-type="pmid">15087470</pub-id>
        </element-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsukazaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Davison</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Attisano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wrana</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>SARA, a FYVE domain protein that recruits Smad2 to the TGFb receptor</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>779</fpage>
          <lpage>791</lpage>
          <comment>doi:S0092-8674(00)81701-8 [pii]</comment>
          <pub-id pub-id-type="pmid">9865696</pub-id>
        </element-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pandolfi</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <article-title>Cytoplasmic PML function in TGF-beta signalling</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>431</volume>
          <fpage>205</fpage>
          <lpage>211</lpage>
          <comment>doi:10.1038/nature02783 nature02783 [pii]</comment>
          <pub-id pub-id-type="pmid">15356634</pub-id>
        </element-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Guglielmo</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Le Roy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Goodfellow</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Wrana</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover</article-title>
          <source>Nat. Cell Biol</source>
          <year>2003</year>
          <volume>5</volume>
          <fpage>410</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="pmid">12717440</pub-id>
        </element-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chawla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Corvera</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2</article-title>
          <source>J. Cell Biol</source>
          <year>2002</year>
          <volume>158</volume>
          <fpage>1239</fpage>
          <lpage>1249</lpage>
          <pub-id pub-id-type="pmid">12356868</pub-id>
        </element-citation>
      </ref>
      <ref id="R60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endofin acts as a Smad anchor for receptor activation in BMP signaling</article-title>
          <source>J Cell Sci</source>
          <year>2007</year>
          <volume>120</volume>
          <fpage>1216</fpage>
          <lpage>1224</lpage>
          <comment>doi:jcs.03400 [pii] 10.1242/jcs.03400</comment>
          <pub-id pub-id-type="pmid">17356069</pub-id>
        </element-citation>
      </ref>
      <ref id="R61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimmel</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Ballard</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Kimmel</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ullmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>Stages of embryonic development of the zebrafish</article-title>
          <source>Dev. Dyn</source>
          <year>1995</year>
          <volume>203</volume>
          <fpage>253</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">8589427</pub-id>
        </element-citation>
      </ref>
      <ref id="R62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrios-Rodiles</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-throughput mapping of a dynamic signaling network in mammalian cells</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>307</volume>
          <fpage>1621</fpage>
          <lpage>1625</lpage>
          <pub-id pub-id-type="pmid">15761153</pub-id>
        </element-citation>
      </ref>
      <ref id="R63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jullien</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gurdon</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Morphogen gradient interpretation by a regulated trafficking step during ligand-receptor transduction</article-title>
          <source>Genes Dev</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>2682</fpage>
          <lpage>2694</lpage>
          <comment>doi:gad.341605 [pii] 10.1101/gad.341605</comment>
          <pub-id pub-id-type="pmid">16260495</pub-id>
        </element-citation>
      </ref>
      <ref id="R64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitsunari</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clathrin adaptor AP-2 is essential for early embryonal development</article-title>
          <source>Mol. Cell. Biol</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>9318</fpage>
          <lpage>9323</lpage>
          <pub-id pub-id-type="pmid">16227583</pub-id>
        </element-citation>
      </ref>
      <ref id="R65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>An electron-microscope and freeze-fracture study of the egg cortex of Brachydanio rerio</article-title>
          <source>Cell Tissue Res</source>
          <year>1991</year>
          <volume>265</volume>
          <fpage>317</fpage>
          <lpage>328</lpage>
          <pub-id pub-id-type="pmid">1934030</pub-id>
        </element-citation>
      </ref>
      <ref id="R66">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jesuthasan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Furrow-specific endocytosis during cytokinesis of zebrafish blastomeres</article-title>
          <source>Exp. Cell Res</source>
          <year>2002</year>
          <volume>279</volume>
          <fpage>14</fpage>
          <lpage>20</lpage>
          <comment>doi:S0014482702955795 [pii]</comment>
          <pub-id pub-id-type="pmid">12213209</pub-id>
        </element-citation>
      </ref>
      <ref id="R67">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Kleist</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of the clathrin terminal domain in regulating coated pit dynamics revelaed by small molecule inhibition</article-title>
          <source>Cell</source>
          <year>2011</year>
          <volume>146</volume>
          <fpage>471</fpage>
          <lpage>484</lpage>
          <comment>doi:S0092-8674(11)00667-2 [pii] 10.1016/j.cell.2011.06.025</comment>
          <pub-id pub-id-type="pmid">21816279</pub-id>
        </element-citation>
      </ref>
      <ref id="R68">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thieman</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clathrin regulates the association of PIPKIÎ³661 with the AP-2 adaptor Î²2 appendage</article-title>
          <source>J. Biol. Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>13924</fpage>
          <lpage>13939</lpage>
          <pub-id pub-id-type="pmid">19287005</pub-id>
        </element-citation>
      </ref>
      <ref id="R69">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edeling</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural requirements for PACSIN/Syndapin operation during zebrafish embryonic notochord development</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>e8150</fpage>
          <pub-id pub-id-type="pmid">19997509</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Binding properties of FCHO1</p>
        <p>(<bold>a</bold>) Cartoon of FCHO1 with the location and relative binding properties of the various truncations tested.</p>
        <p>(<bold>b</bold>) Coomassie-stained gel and blot of supernatant (S) and pellet (P) fractions of a GST pull-down assay with brain cytosol and immobilized GST or the indicated GST-FCHO1 or GST-ARH fragments. Immunoblotted with anti-clathrin heavy chain (HC) and AP-1/2 Î²1/2-subunit antibodies. Molecular mass standards (kDa) are shown, and large adaptor subunits (arrowheads) indicated.</p>
        <p>(<bold>c</bold>) Pull-down assay with FCHO1 overexpressing HeLa cell lysate and immobilized GST or the indicated GST-fusion proteins. Two independent anti-FCHO1 antibodies used for detection. Non-specific bands (asterisks) are indicated.</p>
        <p>(<bold>d</bold>) Pull-down assay with FCHO1 overexpressing HeLa lysates and immobilized GST, GST-Î±<sub>C</sub> appendage or the indicated Î±<sub>C</sub> appendage point mutants.</p>
        <p>(<bold>e</bold>-<bold>l</bold>) Mock or AP-2 Î±-subunit siRNA-treated HeLa cells transfected with either GFP-FCHO1 or GFP-FCHO2 as indicated were incubated with Alexa568 transferrin on ice before fixation. Representative confocal images show AP-2 silencing leads to loss of transferrin clusters on the surface. Insets (f,h,i,l) provide color-separated and merged enlargements of boxed regions. Scale bar: 10 Î¼m.</p>
        <p>(<bold>m</bold>) Confocal image of a region of an AP-2 Î±-subunit siRNA transfected HeLa cell also expressing GFP-FCHO1. Prior to fixation and staining with an anti-clathrin HC mAb, the silenced cells were incubated at 37Â°C with 25 Î¼g/ml Alexa633-labeled transferrin.</p>
        <p>(<bold>n</bold>) Biochemical assessment of AP-2 siRNA silencing in HeLa cell lysates by immunoblotting.</p>
        <p>(<bold>o</bold>-<bold>r</bold>) Representative confocal images of the intracellular localization of full-length (1-889), EFC domain (1-275), ÎÎ¼HD (1-609) or Î¼HD (609-889) GFP-tagged FCHO1 compared with AP-2 (Î± subunit). Insets provide color-separated and merged enlargements of boxed regions. Scale bar: 10 Î¼m.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>The Î¼HD interaction hub</p>
        <p>(<bold>a</bold>) Coomassie-stained gel and blot of supernatant (S) and pellet (P) fractions of a pull-down assay with full-length or ÎÎ¼HD (1-609) FCHO1 overexpressing HeLa lysates and immobilized GST or GST-eps15 (595-896). Immunoblot with anti-FCHO1. Molecular mass standards (kDa) and intact FCHO1 (orange) and ÎÎ¼HD (black arrowheads) FCHO1 are indicated.</p>
        <p>(<bold>b</bold>) Pull-down assay using brain cytosol and either GST or 50 or 100 Î¼g of the GST-Î¼HD fusions indicated or the GST- Î±<sub>C</sub> appendage. Replicate immunoblots probed with the indicated antibodies with non-specific bands (asterisks) indicated.</p>
        <p>(<bold>c</bold>) Pull-down assay using HeLa lysate and either GST or 50 or 100 Î¼g of the GST-Î¼HD fusions indicated. Non-specific bands (asterisks) are indicated. All the GST-Î¼HDs bind to eps15, eps15R, intersectin and Dab2 but only the FCHO1 Î¼HD associates with Hrb, CALM, and clathrin. Note that different eps15 splice isoforms are present in HeLa lysates compared with brain (b).</p>
        <p>(<bold>d</bold>) Stained gel and replicate blots of first-stage assay pellets (red P) from incubations of brain cytosol with either GST or GST-FCHO2 Î¼HD compared with supernatant (S) and pellets (P) from subsequent second-stage pull-downs with the supernatant fractions resulting from the first-stage incubations.</p>
        <p>(<bold>e</bold>) Cartoon of the eps15 C terminus with the relative positioning of the various truncations used indicated.</p>
        <p>(<bold>f</bold>) Pull-down assay using FCHO1 overexpressing HeLa lysate and the indicated GST-eps15 C-terminal fusions. Immunoblot with anti-FCHO1.</p>
        <p>(<bold>g</bold>) Stained gel and replicate blots from pull-down assays with GST or GST-FCHO1 Î¼HD and HeLa lysates supplemented with 5 or 25 Î¼M eps15 (595-660) peptide as indicated.</p>
        <p>(<bold>h</bold>) Interaction diagram for FCHO1/2 and select endocytic pioneer coat components. Presumptive contacts are indicated with dotted lines.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Developmental defects upon <italic>FCHO1</italic> overexpression</p>
        <p>(<bold>a-c</bold>) Representative confocal optical section of 30% epiboly-stage (~5 hpf) embryo injected with a mcRFP-CAAX surface marker (80 pg) and GFP-FCHO1 (400 pg) mRNA after fixation and staining with an anti-AP-2 Î²2 subunit antibody. Subcellular localization (b) and color-separated enlargements (c) of the boxed region. Scale bar: 125 Î¼m.</p>
        <p>(<bold>d</bold>-<bold>i</bold>) Representative morphology of 80 pg control or 200 pg human (<italic>Hs</italic>) <italic>FCHO1</italic> mRNA-injected embryos at 24 hpf with <italic>no tail</italic> and <italic>sonic hedgehog</italic> mRNA expression patterns. Scale bar: 250 Î¼m.</p>
        <p>(<bold>j</bold>) Quantitation of normal (pale blue), mild (navy blue) and moderate (violet) ventralized, or mild (yellow) and severe (brown) mRNA overexpression-induced dorsalized phenotypes, color-coded as in d-i. See <xref ref-type="fig" rid="F4">Fig. 4</xref> and <xref ref-type="fig" rid="F6">6</xref> for complete categorization of the dorsalized and ventralized phenotypic classes.</p>
        <p>(<bold>k</bold>-<bold>l</bold>) Representative morphology of severely affected 200 pg truncated <italic>FCHO1</italic> mRNA-expressing embryos.</p>
        <p>(<bold>m</bold>-<bold>s</bold>) pSmad1/5/8 localization in control (m, p, q), CA*<italic>alk8</italic> (5 pg; n) or <italic>FCHO1</italic> (400 pg; o, r, s) mRNA-injected early gastrulation embryos co-injected with 50 pg mcRFP-CAAX. Wide field (m-o; left) and fluorescence images (m-o; right)) or representative confocal sections (p, r) with color separated and merged enlargements (q, s) of the dorsal organizer region (arrows) shown. D, dorsal; V, ventral. Scale bars: 250 Î¼m (m-o) or 125 Î¼m (p, r).</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Fcho1 participates in early embryonic development</p>
        <p>(<bold>a</bold>-<bold>f</bold>) Representative images of the morphant phenotypic range on injection with 2 ng control or 2 ng <italic>fcho1</italic> MO. C5-like morphants are rare and are grouped with the C4 class. Arrows: ventral fin defects. Scale bar: 250 Î¼m.</p>
        <p>(<bold>g</bold>) Quantitation of dose-dependent <italic>fcho1</italic> morphant phenotypes at 24 hpf, color coded as in a-f.</p>
        <p>(<bold>h</bold>-<bold>i</bold>) Typical vegetal pole view of 10 ng control or 10 ng <italic>fcho1</italic> early-stage morphants at 10 hpf. A, anterior; P, posterior. Arrow: expanded A-P axis. Scale bar: 125 Î¼m.</p>
        <p>(<bold>j</bold>-<bold>m</bold>) Representative mRNA expression patterns of both <italic>krox20</italic> (brackets) and <italic>gata1</italic> (arrows) in control (j, k) or 10 ng <italic>fcho1</italic> MO-injected (l, m) 5-somite stage embryos. A, anterior; P, posterior. Group dorsal survey view: j, l; individual lateral view: k, m. Scale bar: 225 Î¼m (j and l) or 125 Î¼m (k, m).</p>
        <p>(<bold>n</bold>) Schematic cartoon depiction of the general location of opposing morphogen gradients that dictate DV patterning at shield stage. An, animal pole; Vg, vegetal pole; D, dorsal; V, ventral.</p>
        <p>(<bold>o</bold>-<bold>r</bold>) Representative mRNA expression patterns of indicated genes in 10 ng control (o and q) or <italic>fcho1</italic> (p and r) shield-stage morphants. Relative expression zones (arrowhead in animal and bracket in lateral views) shown. Scale bar: 250 Î¼m.</p>
        <p>(<bold>s</bold>-<bold>t</bold>) Dorsal view of gross morphology of developing notochord and somite regions of live 10 ng control (R) and <italic>fcho1</italic> (S) morphants at the 6-somite stage. Scale bar: 50 Î¼m.</p>
        <p>(<bold>u</bold>-<bold>x</bold>) representative phenotypes of 2 ng <italic>fcho1</italic> morphants coinjected with indicated human (<italic>Hs</italic>) <italic>FCHO1</italic> mRNA. Scale bar: 250 Î¼m.</p>
        <p>(<bold>y</bold>) Quantitation of morphant phenotypes at 24 hpf.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0004"/>
    </fig>
    <fig id="F5" orientation="portrait" position="float">
      <label>Figure 5</label>
      <caption>
        <p>The Fcho1âAlk8 association</p>
        <p>(<bold>a</bold>-<bold>d</bold>). Representative images of live 24 hpf embryos after injection of 0.5 or 5 ng <italic>alk8</italic> MO, 0.5 ng <italic>fcho1</italic> MO or 0.5 ng each of <italic>alk8+fcho1</italic> MOs. Defective ventral tail fin is bracketed (green). Scale bar: 250 Î¼m.</p>
        <p>(<bold>e</bold>) Quantitation of single and double morphant phenotypes at 24 hpf.</p>
        <p>(<bold>f</bold>) Coomassie-stained gel and replicate blots from a pull-down assay using Alk8-myc overexpressing HeLa cell lysate and 150 Î¼g immobilized GST or 50 or 150 Î¼g human (<italic>Hs</italic>) GST-FCHO1 Î¼HD or <italic>D. rerio</italic> (<italic>Dr</italic>) GST-Fcho1 or GST-Fcho2 Î¼HDs. Alk8 (arrowheads in pellet (P) fractions) immunoblot with anti-myc. Note both bands of expressed Alk8-myc, probably differentially <italic>N</italic>-glycosylated forms, bind to the FCHO1/Fcho1 Î¼HD. Non-specific bands (asterisks) are indicated.</p>
        <p>(<bold>g</bold>) Pull-down assay using wild-type (WT) or CA*Alk8-myc overexpressing HeLa cell lysate and immobilized GST or GST-<italic>Dr</italic> Fcho1 Î¼HD.</p>
        <p>(<bold>h</bold>) Pull-down assay using Alk8-myc overexpressing HeLa cell lysate and immobilized GST or GST-<italic>Hs</italic> FCHO1 Î¼HD. Addition of the eps15 (595-660) competitor peptide (5 or 25 Î¼M) is indicated.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0005"/>
    </fig>
    <fig id="F6" orientation="portrait" position="float">
      <label>Figure 6</label>
      <caption>
        <p>Fcho1 operates in a genetic Bmp-to-Smad signaling pathway</p>
        <p>(<bold>a-f</bold>) Group survey views of comparative morphology of injected control, 25 pg <italic>bmp2b</italic> with 100 pg <italic>bmp7</italic> mRNA<italic>,</italic> 5 ng each of <italic>fcho1+2+p53</italic> MOs, <italic>bmp2b+bmp7</italic> mRNA along with the <italic>fcho1+2+p53</italic> MOs, 200 pg CA*<italic>smad1</italic> mRNA, or the CA*<italic>smad1</italic> mRNA along with the <italic>fcho1+2+p53</italic> MOs-injected embryos at 24 hpf. Scale bar: 250 Î¼m.</p>
        <p>(<bold>g</bold>) Quantitation of mRNA injected gain-of function (ventralized; black bracketed) and morphant (dorsalized; orange bracketed) phenotypes. The relevant unit for injected mRNA is pg and for MO is ng.</p>
        <p>(<bold>h-m</bold>) Representative images of the range and classification of ventralization phenotypes induced by injection of 25 pg <italic>bmp2b</italic> with 100 pg <italic>bmp7</italic> mRNA at the 1-cell stage. Scale bar: 250 Î¼m.</p>
        <p>(<bold>n</bold>) Schematic of the linear Bmp-dependent signaling pathway including the relative positioning of Fcho1.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0006"/>
    </fig>
    <fig id="F7" orientation="portrait" position="float">
      <label>Figure 7</label>
      <caption>
        <p>AP-2 morphants are unlike <italic>fcho1+2</italic> double morphants</p>
        <p>(<bold>a</bold>-<bold>e</bold>) Representative survey views of comparative morphology of 10 ng control, <italic>ap2a1</italic> or <italic>fcho1+2+p53</italic> morphants at 14 (a, b) and 19 (c-e) hpf. Extruded yolk (arrowheads) and exploded/disintegrating (asterisk) embryos shown. Scale bars: 250 Î¼m.</p>
        <p>(<bold>f</bold>) Quantitation of <italic>ap2a1</italic> MO rescue with mouse (<italic>Mm</italic>) Î±<sub>C</sub>-subunit (<italic>Ap2a2</italic>) mRNA.</p>
        <p>(<bold>g</bold>-<bold>i</bold>) mRNA expression patterns of Fgf signaling genes in control (g), <italic>ap2a1</italic> (h) or <italic>fcho1</italic> (i) shield- or 30% epiboly-stage morphants. The zones of expanded expression (brackets) are indicated; D, dorsal; V, ventral. Scale bar: 250 Î¼m.</p>
        <p>(<bold>j</bold>) Restoration of <italic>dusp6</italic> expression in 30% epiboly (~5 hpf) <italic>ap2a1</italic> MO embryos by coinjection of mouse <italic>Ap2a2</italic> mRNA. Zone of expansion without rescue (brackets) indicated.</p>
        <p>(<bold>k</bold>-<bold>m</bold>) Fgf-dependent GFP expression in live embryos injected with 10 ng control, <italic>ap2a1</italic> or <italic>fcho1+fcho2+p53</italic> MOs. Delaminating ectoderm, broadly expanded GFP expression (arrowheads) in <italic>ap2a1,</italic> and diminished ventral tissue (bracket) in <italic>fcho1+2</italic> morphants shown. A, anterior; P, posterior; mhb, mid-hindbrain boundary; r4, rhombomere 4; Kv, Kupferâs vesicle. Elliptical <italic>fcho1</italic> morphant (orange arrow) shown in m. Scale bar: 250 Î¼m.</p>
        <p>(<bold>n</bold>-<bold>p</bold>) mRNA expression profiles of early patterning signaling components in control (n), <italic>ap2a1</italic> (o) or <italic>fcho1</italic> (p) shield- or 30% epiboly-stage morphants. Arrowheads and brackets show zones of expanded expression. Scale bar: 250 Î¼m.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0007"/>
    </fig>
    <fig id="F8" orientation="portrait" position="float">
      <label>Figure 8</label>
      <caption>
        <p>AP-2âclathrin coats persist in FCHO1 and FCHO2 siRNA-treated HeLa and BS-C-1 cells.</p>
        <p>(<bold>a</bold>) Biochemical validation of FCHO1 transcript silencing in GFP-FCHO1-expressing HeLa cells by immunoblot analysis of lysates from mock or FCHO1 siRNA transfected cells. An ON-TARGET plus SMART pool (siRNA<sub>p</sub>; Dharmacon) was used. Replicate immunoblot with an anti-Î² tubulin mAb to verify equivalent loading of lysates.</p>
        <p>(<bold>b</bold>) HeLa cells subject to mock, FCHO1 or FCHO2 siRNA<sub>p</sub> silencing and also ectopically expressing GFP-FCHO1 (along with RFP to mark co-transfected cells) were fixed and stained with Hoechst 33258. Representative, color-separated or merged, confocal optical sections are show. Note that both the FCHO1 and FCHO2 siRNA<sub>p</sub> sets efficiently quench the GFP-FCHO1 fluorescence. Scale bar: 10 Î¼m.</p>
        <p>(<bold>c</bold>) Biochemical verification of FCHO2 siRNA<sub>p</sub>- or siRNA<sub>s</sub>-mediated silencing in HeLa cells by immunoblotting. SDS-PAGE resolved lysates from cells subjected to the indicated treatments were immunoblotted with antibodies against either GFP or FCHO2 and Î² tubulin as a loading control. Notice that the FCHO2 siRNA<sub>p</sub> suppresses both the transfected GFP-FCHO2 as well as the endogenous protein in these cell populations highly efficiently.</p>
        <p>(<bold>d-e</bold>) Representative single confocal optical sections of HeLa cells subjected to mock (d) or combined FCHO1+FCHO2 siRNA<sub>p</sub> (e) followed by fixation and immunodetection of the endogenous AP-2 Î± subunit using mAb AP.6. Note that although the roughly regular patterning and surface density of AP-2âclathrin structures is diminished upon knockdown of FCHO1/2, AP-2-positive puncta still persist and, generally appear to increase in size and are more irregularly deposited (arrowheads).</p>
        <p>(<bold>f</bold>) Biochemical verification of FCHO1+FCHO2 siRNA<sub>p</sub>- or siRNA<sub>s</sub>-mediated silencing in BS-C-1 cells by immunoblotting. Notice, again, that the Stealth (Invitrogen) FCHO2 siRNA<sub>s</sub> very effectively extinguishes the endogenous FCHO2 in these populations of cells. Mock transfected HeLa cells included for comparison.</p>
        <p>(<bold>g-j</bold>) Representative single confocal optical sections of clathrin LCa-GFP expressing BS-C-1 cells subjected to mock (g) or combined FCHO1 siRNA<sub>p</sub>+FCHO2 siRNA<sub>s</sub> (h) followed by fixation and immunodetection of the endogenous AP-2 Î± subunit using mAb AP.6. The insets (i, j) show a color-separated enlarged region corresponding to the boxed area in h. Surface AP-2-positive puncta clearly persist in these FCHO1+2-silenced BS-C-1 cells as well (arrowheads). Note that only a subset of clathrin-labeled structures is AP-2 positive in both the mock and FCHO1+2-silenced cells, as clathrin normally assembles on other intracellular structures as well. Scale bar: 10 Î¼m.</p>
      </caption>
      <graphic xlink:href="nihms-360591-f0008"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>